Dostarlimab in Combination with Chemotherapy for the Treatme

Mansoor R. Mirza, MD, reviews data from the phase 3 RUBY trial investigating dostarlimab in combination with carboplatin and paclitaxel for the treatment of primary advanced or recurrent endometrial cancer.

Related Keywords

Mansoorr Mirza , , Primary Advanced , Recurrent Endometrial Cancer , Placebo Controlled Randomized Phase , Dostarlimab , Endometrial Cancer , Chemotherapy , Advanced Endometrial Cancer , Primary Advanced Endometrial Cancer , Placebo Controlled , Engot En6 Nsgo , Gog 3031 , Ruby , Ruby Trial , Ruby Study , Ruby Endometrial Cancer , Ruby Endometrial Carcinoma ,